Displaying 1 - 7 of 7 for Cancer - Hematology
  • MOHEL Study (H-8701)
    • Subjects are being asked to participate in this study because treatment of their disease requires them to receive a stem cell transplant.
  • Prevention of Graft-versus-Host Disease Study (H-36264)
    • The purpose of this study is to compare calcineurin inhibitor (CNI)-free strategies for graft-versus-host disease (GVHD) prophylaxis to standard tacrolimus and methotrexate (Tac/Mtx) in patients with hematologic malignancies.
  • Primary Haemophagocytic Lymphohistiocytosis Study (H-33362)
    • The purpose of this study is to assess the safety, tolerability and efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytosis.
  • RELY-30 Study (H-37966)
    • In this study lymphodepletion chemotherapy will be administered in patients who are not post autologous transplant in the hope that it will result in more durable anti-tumor effects.
  • REMAIN Study (H-40203)
    • This trial studies how well nivolumab works in eliminating any remaining cancer cells and preventing cancer from returning in patients with acute myeloid leukemia who had a decrease in or disappearance of signs of cancer after receiving chemotherapy.
  • Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (H-36160)
    • The purpose of this study is to investigate the effects of sertraline in people with low-risk myelodysplastic syndrome (MDS).
  • UCAML Study (H-26558)
    • This study uses umbilical cord stem cells following high dose chemotherapy to treat patients with myeloid hematological malignancies.